Error: Could not add to watchlist. X
+ Watchlist

Bellevue Funds Lux - BB Adamant Biotech

BBBIOEB:LX
480.35
EUR
3.24
0.67%
As of 8:22 AM EDT 7/26/2016
Fund Type
SICAV
52Wk Range
401.45 - 694.81
1 Yr Return
-29.10%
YTD Return
-20.23%
Previous Close
483.59
52Wk Range
401.45 - 694.81
1 Yr Return
-28.77%
YTD Return
-20.23%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 07/26/2016)
480.35
Total Assets (m USD) (on 07/26/2016)
65.887
Inception Date
04/02/2009
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
SAMUEL STURSBERG / JOHN MANIERI
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.60%
Expense Ratio
2.32%

Top Fund Holdings

Name Position Value % of Fund
48.00 k 4.73 m 7.95
52.50 k 4.38 m 7.35
28.50 k 4.34 m 7.28
17.70 k 4.28 m 7.18
10.00 k 3.49 m 5.86
34.00 k 2.72 m 4.56
17.80 k 2.50 m 4.19
18.40 k 2.15 m 3.61
24.00 k 2.06 m 3.46
25.00 k 1.95 m 3.26
Profile
Bellevue Funds (Lux) - BB Adamant Biotech is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests mainly in equities and equity related securities of companies that are directly involved in the biotechnology sector.
Address
Bellevue Group AG
Seestrasse 16
Postfach
8700 Kuesnacht
Zurich
Phone
41-44-267-67-00